Search results
23 mar 2021 · It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
- Recommendations
Recommendations - Overview | COVID-19 rapid guideline:...
- Update Information
Update information. 8 May 2024 We updated the guidance on...
- Tools and Resources
Tools and Resources - Overview | COVID-19 rapid guideline:...
- History
History - Overview | COVID-19 rapid guideline: managing...
- ID6261
Evidence-based recommendations on remdesivir (Veklury) and...
- 5 Supporting Information on Risk Factors for Progression to Severe Covid-19
5 Supporting information on risk factors for progression to...
- Antimicrobial Stewardship
These guidelines are evidence-based and clinical syndrome...
- Evidence
Evidence - Overview | COVID-19 rapid guideline: managing...
- Recommendations
1 lip 2016 · Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards. ... (180) COVID-19 rapid guidelines (3) Diagnostics guidance (37) Health technology evaluations ... Jaundice in newborn babies under 28 days: CG98: 19 May 2010: 31 October 2023:
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
25 sty 2024 · This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19.
25 sty 2024 · This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19.
23 mar 2021 · It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections
A guide to evidence collection for medicines, plus free scientific advice for researchers developing novel diagnostics or therapeutics for COVID-19. All NICE products on COVID-19. Includes any guidance and advice.
